Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity

We developed antitumor NPs and MVs that efficiently induced antitumor immune responses in vivo by simultaneously delivering multiple immunostimulatory signals to endogenous T cells. This platform enables the delivery of desired combinations of antitumor immune signals into T cells and NK cells.